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Abstract 
Objectives: We aimed to estimate the incidence of ANCA-associated 
vasculitis in the UK and how this varied by ethnic group. 
Methods: We identified incident cases of ANCA-associated vasculitis 
between March 2007 and June 2013 in the Nottingham-Derby urban area 
from medical records using multiple sources. We derived the denominator 
population from the 2011 census, and we calculated incidence rate ratios 
using Poisson regression. 
Results: Overall we identified 107 cases of ANCA-associated vasculitis, 
giving an incidence of 23.1/million person-years (95% CI 18.9-27.9). The 
incidence among the White population was 25.8/million person-years 
(95% CI 21.0–31.3), and among the Black and minority ethnic (BME) 
population was 8.4/million person-years (95% CI 3.1-18.3). After 
adjustment for age and sex, the difference between ethnic groups was 
not statistically significant (incidence rate ratio 0.7, 95% CI 0.3-1.5, 
p=0.3). 
Conclusions: Overall the incidence of ANCA-associated vasculitis was 
similar to other epidemiological studies. Crude incidence rates were lower 
in the BME than White population but this was partly explained by the 
older age profile among the White compared to BME population. 
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Main text 
Background: 
The evidence base for the epidemiology of ANCA-associated vasculitis is 
limited. However, the incidence has been studied in a number of 
populations globally but these are predominantly White (1). Several 
studies have suggested that the occurrence of ANCA-associated vasculitis 
may be less in non-White ethnic groups, but there has not been a detailed 
study of the incidence in a multiethnic European population. There are no 
data on the incidence of ANCA-associated vasculitis in different ethnic 
groups relevant to the Black and minority ethnic (BME) populations in the 
UK. Such data are important for health services planning to ensure equal 
access to services for all ethnic groups, and to give insights into disease 
aetiology. The population of the Nottingham-Derby urban area is 
multiethnic, therefore, as part of an audit of service provision and 
outcome of patients with ANCA-associated vasculitis, we recorded the 
pre-existing data on the ethnicity of patients attending our vasculitis 
services. 
The aim of this analysis was to calculate the incidence of ANCA-associated 
vasculitis in Nottingham and Derby, and how this varied by ethnic group. 
Method:  
We completed a retrospective case note review of all adults (aged > 16 
years) with newly diagnosed ANCA-associated vasculitis who were 
resident within the Nottingham-Derby urban area during a 6.25 year 
period (March 2007 – June 2013). We chose this start date because a 
new laboratory database was introduced in Nottingham in March 2007, 
and it was not possible to access laboratory results prior to this date. The 
stop date for patient inclusion was June 2013. 
 
Study area and denominator population 
The Nottingham and Derby Urban Areas are contiguous (Fig 1). Together 
they cover an area of 237 km2. This combined area is geographically 
distinct from other cities, and people with ANCA-associated vasculitis are 
referred to either Nottingham University Hospitals NHS Trust or the Royal 
Derby Hospital hence this was a good location to capture an incident 
cohort. We verified the boundary by speaking to General Practitioners on 
the periphery, about their referral practices, and to rheumatologists in 
Mansfield (to the North) and Leicester (to the South) to confirm they did 
not see people with ANCA-associated vasculitis from within our catchment 
area. This study is limited to people who received healthcare at a national 
health service (NHS) hospital, however as NHS care is universal and free 
at the point of use, we expect this to include the overwhelming majority 
of people. 
 
We used the results from the Office for National Statistics (ONS) 2011 
census to provide the denominator population (2). This was available 
broken down by age, sex and ethnicity for each middle layer super output 
area (MSOA, an ONS sub-division of England with an average population 
of around 7000). The index of multiple deprivation 2015 (IMD15) was 
used as a measure of social deprivation, but these data were not available 
at individual patient level, only by lower layer super output area (LSOA, 
an ONS sub-division of England, areas with about 1500 people) so a 
separate analysis was performed as these data could not be included as a 
variable in the main analysis. 
 
Figure 1 Study area: The continuous Nottingham and Derby urban areas. The area 
enclosed by the red line is the study population. (Map reproduced with permission from 
Kiln) 
 
Sources of case ascertainment 
Patients were identified from the hospital trust in Nottingham from 5 
sources, 1) rheumatology departmental register, 2) renal departmental 
database search, 3) positive MPO/PR3 ANCA results, 4) histopathology 
laboratory database of biopsies coded for vasculitis (SnoMed codes), and 
5) inpatient discharges coded as vasculitis using ICD 10 codes M301 
polyarteritis with lung involvement (eosinophilic granulomatosis with 
polyangiitis [EGPA]-Churg Strauss), M313 granulomatosis with 
polyangiitis (GPA-Wegener’s granulomatosis) and M317 microscopic 
polyangiitis (MPA). The study was carried out first in Nottingham, and as 
review of inpatient discharges and biopsies had only identified one extra 
patient we did not perform these additional reviews in Derby. Therefore, 
patients at the hospital in Derby were identified from 3 sources: 1) 
rheumatology department database search, 2) renal departmental 
database search and 3) positive MPO/PR3 ANCA results. 
 
Case definition 
People met the study definition of ANCA-associated vasculitis if they 
fulfilled 4 criteria: 1) new diagnosis of ANCA-associated vasculitis between 
1 March 2007 and 30 June 2013, 2) residence within the study area at the 
time of diagnosis 3) positive ANCA by indirect immunofluorescence or 
ELISA, and 4) ANCA-associated vasculitis that was classifiable according 
to the EMA classification algorithm(3) which has been previously validated 
for use in epidemiological studies. This algorithm combines the Chapel Hill 
Consensus definitions for ANCA-associated vasculitis, standard disease 
classification criteria for GPA, MPA and EGPA, as well as including 
surrogate markers for upper airways granuloma and for renal vasculitis 
and ANCA. This was performed by FP. If there was uncertainty about 
diagnosis or classification, the case details were reviewed by PCL, RAW 
and Dr Al Ferraro (in Nottingham) or Dr J Leung (in Derby). 
 Data collection 
In keeping with our audit protocol, data were extracted from the existing 
medical records on demographics (age, sex, ethnicity), postcode at time 
of diagnosis, clinical features sufficient to apply the EMA classification 
algorithm, ANCA status, and mortality. Postcode at time of diagnosis was 
used to determine residence within the study area, and to determine 
Middle layer super output area using the Office for National Statistics 
‘Neighbourhood statistics’ website(4). Postcode was also used to look up 
the IMD15 quintile for the patient’s Lower layer super output area (LSOA), 
where 1 denotes the most deprived 20% of LSOAs, and 5 the least 
deprived 20% of LSOAs. Ethnicity was ascertained from self-reported 
ethnicity recorded on the hospital patient information system using the 
16+1 codes used by the health and social care information centre(5). 
 
Data capture/recapture analysis was performed to estimate completeness 
of case ascertainment. This technique fits log-linear models to tables of 
the frequencies of which sources patients appeared in, and based on the 
overlap between the sources estimates the number of cases missed by all 
the sources and a confidence interval (6,7). This was done separately in 
Nottingham and Derby, as the sources were different.  
To estimate the number of incident cases of ANCA-associated vasculitis in 
the UK in 2014, and projected numbers in 2024 and 2034 we used direct 
standardization of the incidence rates calculated by age group to the ONS 
estimates for the UK population by age-group. 
 
Statistical analyses 
We categorised age into groups (16-39, 40-54, 55-69, 70-84 and 85+ 
years), and ethnicity into White, Black, Indo-Asian, Other Asian and 
Other/mixed ethnic groups. Ethnicity was also coded as a binary variable 
(White vs Black and minority ethnic [BME]) to increase statistical power. 
We calculated crude incidence rates (and Poisson 95% confidence 
intervals [95% CI]) per million person-years, and stratified these by age, 
ethnic group, and sex. Poisson regression modelling was applied firstly to 
one variable at a time, then all were included in a multi-variable model to 
control for age and sex. Due to the small size of this dataset, the Poisson 
regression model was re-run just for White versus all BME groups 
controlling for age and sex. We could not include socio-economic status in 
the main analysis as these data were not available at the individual 
patient level, instead they are only available as IMD-15 deprivation scores 
applied to each LSOA (areas of about 1500 people). The number of 
patients in each deprivation quintile was compared with the number 
expected in each quintile based on the deprivation scores (quintiles) 
assigned to all 567 LSOAs covered by the study area and the differences 
between these observed and expected values were compared using a chi-
square test.  
 
All analyses were performed using Stata 13 statistical software 
(Statacorp, Texas, USA)(8), except for the data capture/recapture 
analysis for a closed population which was performed using R-3.2.2 (R 
Core Team 2015), package RCapture(9). 
 
Ethical aspects 
This study was approved by the Nottingham University Hospitals NHS 
Trust and Royal Derby Hospitals NHS Trust clinical audit departments, as 
a service evaluation component of an audit against the BSR Guidelines for 
the Management of adults with ANCA-associated vasculitis, April 2013. 
(Nottingham University Hospitals NHS Trust audit department Project 
number 13-037C; Royal Derby Hospitals NHS Trust audit department 
project number RB-Rhe-2014/15-48). 
Results: 
The 2011 census adult (≥16 years) population within our defined area 
was 741071 adults (51% female). The ethnic breakdown for adults in this 
area was: 84.6% White and 15.4% BME (6.1% Indo-Asian, 2.4% other 
Asian, 3.4% Black, 3.5% mixed/ multiple/other ethnic groups). 
In Nottingham we identified 1354 possible ANCA-associated vasculitis 
patients on the renal department register (50), rheumatology department 
register (54), positive MPO/PR3 ANCA results (812), pathology laboratory 
database of biopsies coded for vasculitis (207), renal biopsies with ANCA-
associated vasculitis (87), and inpatient discharges coded as vasculitis 
(144). Patients failed to fulfill the entry criteria for the following reasons: 
residence outside the study area at time of diagnosis, or diagnosis before 
or after the study timeframe, or no diagnosis of ANCA-associated 
vasculitis according to the EMA classification criteria, or a combination of 
these. Biopsy review and review of inpatient records only yielded one 
patient not identified by other means. Review of these 1354 records 
identified 64 patients who met the study inclusion criteria (see table 1). 
In Derby, we identified 572 possible patients on the renal department 
register (106), rheumatology department register (79), and positive 
MPO/PR3 ANCA results (387). Review of these 572 records identified 43 
patients who met the study inclusion criteria (see table 1). The reason 
why some patients are included but do not appear on the list of positive 
MPO/PR3 results is that they were ANCA positive by indirect 
immunofluorescence only, and MPO/PR3 negative in our laboratory. 
 
Overall we identified 107 incident cases of ANCA-associated vasculitis 
during the 6.25 year period in the denominator population. The 
demographic and clinical characteristics of the incident cases are shown in 
table 2. The majority of cases were men (60%) and median age at 
diagnosis was 70.2 (interquartile range [IQR] 58.4-78.6) years. 94.4% of 
cases were white, 1.9% were Black, 2.8% were Indo Asian, and 0.9% 
were other Asian. There were no cases among other or mixed ethnic 
groups. The overall annual incidence of ANCA-associated vasculitis was 
23.1/million person-years (95% CI 18.9-27.9). 
 The incidence rates of GPA, MPA and EGPA were 8.2/million (95% CI 5.8–
11.3), 13.4/million (95% CI 10.3–17.2) and 1.5/million (95% CI 0.6–3.1) 
respectively. The incidence of MPO-ANCA vasculitis was 11.9/million (95% 
CI 8.9-15.5) and PR3-ANCA vasculitis was 10.8/million (95% CI 8.0-
14.2). There were a higher number of MPO+ patients (51.4%) compared 
to PR3+ patients (46.7%), and 3 patients (2.8%) were p-ANCA+ but 
MPO/PR3 negative. 
 
Stratified crude incidence rates and incidence rate ratios (IRR) are 
presented in table 3. There was a marginal increase in the incidence in 
males compared to females (IRR 1.5, 95% CI 1.0-2.3]), and a dose-
related increased incidence with increasing age, with the IRR for 40-55 
age group compared to the 16-39 age group of 4.1 (95% CI 1.6-10.7) 
and increasing to 31.1 (95% CI 11.6-84.7) for the 85+ age category 
compared to 16-39 age group. Prior to adjustment, there was a 
significantly lower incidence of ANCA-associated vasculitis among the BME 
population compared to the White population (IRR 0.3, 95% CI 0.1-0.7]). 
 
In the adjusted analysis (table 3b) the effect of ethnicity was reduced 
with IRR among BME people compared to White people of 0.7 (95% CI 
0.3-1.5). Males had a higher risk of ANCA-associated vasculitis than 
females with an adjusted IRR of 1.8 (95% CI 1.2-2.6, p=0.004). Age had 
a large influence on incidence, with an IRR of 4.0 (1.5-10.4) for the 40-55 
age group and 32.3 (95% CI 11.9-88.3) for the 85+ age group (reference 
group 16-39 years, p for trend<0.001). 
 
A chi-squared test to compare the distribution of IMD15 among cases 
compared to the number expected based on the distribution of 
deprivation scores in the whole study area was not statistically significant 
(p=0.2). 
 
The results of direct standardization of the incidence rates by age group 
from this study to the ONS estimates for the UK population by age-group, 
give the estimated number of cases of ANCA-associated vasculitis in the 
UK and are shown in table 5. The estimated number of incident cases in 
2014 was 1348, predicting a rise to 1600 in 2024 and 1835 in 2034. 
 
Capture/recapture analysis confirmed that overall there was a high 
degree of completeness of case capture within in our population (see 
table 4). In Nottingham the best-fitting model suggests we missed 0.3 
cases (95% CI 0-1.5), and Derby 0.6 (95% CI 0-2.6) cases, giving an 
overall total of 0.9 missed cases. This best fitting model assumed 
independence between the three lists in their ability to identify cases. 
  
Table 1: Numbers of patients on each list, and numbers included in the analysis 
List Patients on list with 
possible AAV (n) 
Had a diagnosis of AAV & met the study 
geographical and time inclusion criteria (n) 
Nottingham 
Rheumatology register 
54 28 
Nottingham Renal register 50 21 
Nottingham Positive 
MPO/PR3 
812 62 
Nottingham Discharges 144 21 
Nottingham Renal 
biopsies register 
87 31 
Nottingham Biopsies 207 4  
Total in Nottingham 1354 64 
Derby Rheumatology 
register 
79 7 
Derby Positive MPO/PR3 387 42 
Derby Renal register 106 21 
Total in Derby 572 43 
Total Included  107 
There were 2 patients with positive ANCA (by indirect immunofluorescence) but negative MPO/PR3 ANCA who 
were included in the study, which is why they did not appear on the positive MPO/PR3 lists. There was also 1 
patient we missed due to human error. 
Table 2: Demographics and clinical characteristics of the 107 incident cases 
Demographics  
Female, n (%) 43 (40.2) 
Male, n (%) 64 (59.8) 
Median Age (yrs) (IQR) 70.2 (58.4-78.6) 
Ethnicity, n (%)  
White 101 (94.4) 
Black 2 (1.9) 
Indo Asian 3 (2.8) 
Other Asian 1 (0.9) 
Other 0 (0) 
Clinical Characteristics  
Diagnosis, n (%)  
EGPA 7 (6.5) 
GPA 38 (35.5) 
MPA 62 (57.9) 
ANCA, n (%)  
PR3 50 (46.7) 
MPO 55 (51.4) 
IIF only 2 (1.9) 
Active urinary sediment, n (%) 70 (65.4) 
GN on renal biopsy, n (%) 63 (58.9) 
ESRD, n (%) 29 (27.1) 
Pulm Haemorrhage, n (%) 17 (15.9) 
Dual GBM disease, n (%) 3 (2.8) 
Death within 3 months, n (%) 14 (13.1) 
Death within 1 year, n (%) 21 (19.6) 
Active urinary sediment defined as ≥2+ blood & ≥2+ protein on urinalysis (3). GN:  glomerulonephritis; ESRD: 
End Stage Renal Disease; Pulm Haemorrhage: pulmonary haemorrhage; GBM: Diagnosis of dual AAV and Anti-
glomerular basement membrane (anti-GBM) disease.  
Table 3: Incidence rates (5 Ethnicity categories) 
 Cases Denominator 
population 
Crude incidence rates 
(95% CI) per million 
person-years 
Ethnicity    
White 101 627103 25.8 (20.7-30.8) 
BME 6 113968 8.4 (3.1-18.3) 
      Black 2 25231 12.7 (1.5-45.8) 
      Indo-Asian 3 45337 10.6 (2.2-30.9) 
      Other Asian 1 17537 9.1 (0.2-50.8) 
      Other 0 25863 0 (0-22.8) 
    
Sex    
Female 43 376931 18.3 (13.2-24.6) 
Male 64 364140 28.1(21.7-35.9) 
    
Age group    
16-39 years 6 325168 3.0(1.1-6.4) 
40-54 years 14 184233 12.2(6.6-20.4) 
55-69 years 33 133053 39.7(27.3-55.7) 
70-84 years 43 79578 86.4(62.5-116.5) 
85+ years 11 19039 92.4(46.1-165.4) 
    
        
Table 4: Incidence rates and Poisson regression modelling (2 Ethnicity categories) 
 Cases Denominator 
population 
Unadjusted Rate ratios 
(95% CI) using single 
variable Poisson 
regression 
Adjusted Rate ratios (95% 
CI) using multi-variable 
Poisson regression 
Ethnicity     
White 101 627103 1.0 1.0 
BME 6 113968 0.3(0.1-0.7) 0.7 (0.3-1.5) 
    P=0.3 
Sex     
Female 43 376931 1.0 1.0 
Male 64 364140 1.5(1.0-2.3) 1.8 (1.2-2.6) 
    P=0.004 
Age group     
16-39 years 6 325168 1.0 1.0 
40-54 years 14 184233 4.1(1.6-10.7) 4.0(1.5-10.4) 
55-69 years 33 133053 13.4(5.6-32.1) 12.8(5.3-30.6 
70-84 years 43 79578 29.3(12.5-68.6) 28.6(12.1-67.5) 
85+ years 11 19039 31.3(11.6-84.7) 32.3(11.9-88.3) 
    P trend <0.001 
         Overall p<0.0001  
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Table 5: Data Capture-Recapture analysis using 3 sources 
Nottingham 
Rheum/Renal 
list 
+ve 
ANCA 
list 
Biopsy/Discharge 
list Frequency 
model Mean 
estimate of 
cases 
SE p AIC BIC 
1 0 0 1 c1+c2+c3 64.3 0.6 0.47 32.55 41.18 
1 1 0 17 c1+c2+c3+c1*c2 64.7 1.1 0.4 33.81 44.6 
1 1 1 25 c1+c2+c3+c1*c3 64.3 0.6 0.29 34.5 45.29 
1 0 1 0 c1+c2+c3+c2*c3 64.5 0.9 0.33 34.25 45.04 
0 1 1 12 c1+c2+c3+c1*c2+c1*c3 64.7 1.1 0.18 35.79 48.75 
0 1 0 8 c1+c2+c3+c1*c2+c2*c3 4851652095 2.04 e14 0.97 34.02 46.97 
0 0 1 1 c1+c2+c3+c1*c3+c2*c3 64.5 0.9 0.14 36.22 49.17 
    c1+c2+c3+c1*c2+c1*c3+c2*c3 4756521589 2 e14 1 36.02 51.13 
Derby 
Rheum list 
Renal 
list +ve ANCA Frequency Model 
Mean 
estimate of 
cases 
SE p AIC BIC 
1 1 1 1 c1+c2+c3 43.8 1.2 0.19 29.88 36.92 
1 1 0 0 c1+c2+c3+c1*c2 43.6 1 0.74 27.68 36.49 
1 0 1 6 c1+c2+c3+c1*c3 44.1 1.6 0.13 31.19 40.00 
1 0 0 0 c1+c2+c3+c2*c3 43 0 0.1 31.55 40.36 
0 1 1 19 c1+c2+c3+c1*c2+c1*c3 43.8 1.3 1 29.07 39.64 
0 1 0 1 c1+c2+c3+c1*c2+c2*c3 43 0 0.75 29.17 39.74 
0 0 1 16 c1+c2+c3+c1*c3+c2*c3 44 13331.2 0.04 33.19 43.76 
    c1+c2+c3+c1*c2+c1*c3+c2*c3 43.1 13825.3 1 31.07 43.40 
Best-fitting model in bold typeface for Nottingham and Derby, indicated by having the lowest Akaike information criterion (AIC) and lowest Bayesian information 
criterion (BIC)(10). 
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Discussion 
This study adds to the information on incidence of ANCA-associated vasculitis 
in the literature and is the first report to describe the incidence of ANCA-
associated vasculitis in a multi-ethnic population from the UK. The main 
findings are that increasing age was strongly associated with increased disease 
incidence, and male sex marginally so. The crude incidence of ANCA-associated 
vasculitis was significantly lower in the BME population compared to the White 
population, however once adjusted for age and sex it was not statistically 
significant at a 5% level. This shows that the association between lower 
incidence of ANCA-associated vasculitis and BME ethnicities in the unadjusted 
analysis is partly explained by the age structure of the White population in 
Nottingham and Derby which is on average older than the BME population. The 
lack of statistical significance of the adjusted result may reflect in part the 
small size of this study, and a larger study with greater statistical power is 
needed to better estimate if there is a true difference in incidence between the 
ethnic groups or whether this occurred by chance. It was not possible to 
include social deprivation in the multivariable analysis, as data on the 
denominator population were available by ethnicity, age and sex, but not social 
deprivation. However, a chi-squared test of the distribution of IMD15 among 
cases compared to the whole study area showed no significant difference. 
Under the assumption of the incidence remaining stable over time, we 
estimate a 34% increase in the number of incident cases of ANCA-associated 
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vasculitis seen annually in the UK over the next 20 years, based on the 
predicted aging of the population. 
 
The main strength of the study is robust case ascertainment of an incident 
cohort. The case ascertainment strategy was designed to minimise bias 
towards specific manifestations of ANCA-associated vasculitis – in particular 
the strategy of examining the case notes of all people with a positive MPO/PR3 
ANCA or a biopsy (from any organ) which was coded as showing ‘vasculitis’. 
This was in addition to the lists held by the Renal and Rheumatology 
departments which might omit predominantly ENT/neurological/respiratory 
cases, however, local practice in both hospitals in the study is for 
ENT/neurological and respiratory cases of ANCA-associated vasculitis to be 
referred to Rheumatology for administration of immunosuppression and hence 
would have been identified. The data capture/recapture analysis showed good 
completeness of case finding, however this does not estimate patients missed 
completely by the hospitals in the study, for example by dying before 
diagnosis, or by seeking their healthcare elsewhere. To address these issues 
we made efforts to include patients who died very soon after diagnosis, and 
our survival of 86.9% at 3 months (table 2) which is lower than previous 
published studies(10,11) suggests that we were successful. Also to address 
these issues, the boundaries of the study area were drawn conservatively close 
to the catchment hospitals to maximize the chance of patients being treated at 
those hospitals. Discussions with colleagues in neighbouring institutions 
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indicated that it was unlikely that patients from our catchment population 
would have been referred elsewhere. A review of the literature shows that 
methods for determining hospital catchment areas are historically contentious, 
and what is more, catchment areas may not be the same for different services 
based in the same hospital or Trust (12–15). However, the catchment area as 
defined by acute admissions in 2009 for Nottingham and Derby hospitals was 
1,330, 624(16) and our population was only the 741,070 adults closest to the 
city centres, which provides some reassurance that the area we chose is 
conservative enough. 
 
Inherent to all studies of rare diseases, the main weakness of this study is lack 
of power. Although the BME denominator population was 113967 and was 
followed for 6.25 years, there were only 6 incident cases of ANCA-associated 
vasculitis. Thus we were unable to determine the incidence rates for different 
minority ethnicities. The study was conducted across two hospital catchment 
areas to increase the size of the study population. The time-consuming nature 
of the methods of case ascertainment made it unfeasible to extend the study 
area further. 
 
Overall our incidence figure is in line with that observed in a similar population 
based studies from 2005-2009 in Norfolk (UK) and in Japan(17) where the 
incidence of ANCA-associated vasculitis was 21.8 (95% CI 12.6-30.9) and 22.6 
(95% CI 19.1-26.2) per million person-years, respectively. There have been 
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studies from Europe, Japan, USA, New Zealand and Canada using different 
methods of case ascertainment, and of case definition, reporting incidence 
rates of ANCA-associated vasculitis that range from 13 to 20/million person-
years(1). The reason for our incidence rate being at the top end of this range 
is partly that incidence estimates increased during the 1990s when ANCA 
testing became routinely available, and also that we used a more stringent 
method of case ascertainment than most studies. 
 
Unexpectedly, our study found the incidence of Microscopic polyangiitis 
(13.4/million, 95% CI 10.3–17.2) to be higher than of Granulomatosis with 
polyangiitis (8.2/million, 95% CI 5.8–11.3), and the incidence of MPO+ ANCA-
associated vasculitis (11.9/million, 95% CI 8.9-15.5) to be higher than that of 
PR3+ ANCA-associated vasculitis (10.8/million, 95% CI 8.0-14.2). In 
comparison to the previous study by Watts et al(18) in Norfolk which found the 
incidence of GPA to be 11.3, 9.1-13.4) and MPA to be 5.9 (4.4-7.5), the two 
studies used the same case definitions and the same strategy of retrospective 
case note review. However there were differences in case-finding strategies – 
the Norfolk study did not ascertain cases from all positive MPO/PR3 ANCA 
tests. Our results are most similar to Mohammad et al’s study from Sweden 
which used a similar strategy of case ascertainment to our study and 
estimated the overall incidence of AAV to be 20.9 (17.3 – 24.4), and the 
incidence of MPA (10.1, 95% CI 7.7-12.6) to be higher than the incidence of 
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GPA (9.8, 95% CI 7.4-12.2)(19). As yet undefined environmental factors may 
also contribute to these differences. 
 
It is difficult to compare the findings of our incidence study to studies of 
prevalence, as prevalence is influenced by survival as well as incidence. 
However, it is interesting to note the previous observation that the prevalence 
of ANCA-associated vasculitis in a multi-ethnic population of the greater 
metropolitan Paris area was two-fold higher in the subjects of European 
ancestry compared to the non-Europeans(20) would be compatible with our 
study. Ignoring any possible differences in survival between ethnic groups, 
which would affect prevalence, our unadjusted incidence rate for Whites 
compared to BME was about triple.  
 
In this paper we are not able to comment on whether differences in risk of 
disease in people with different self-reported ethnicities relate to their racial 
(genetic) origins or social and cultural practices. Recent data suggests that the 
White population of central England is homogeneous and is of Northern 
European Caucasian race (21) and our overall incidence is comparable with 
incidence figures from other studies in Northern European populations(1). 
 
This study estimates projected UK numbers of incident cases for future 
planning of services for patients with ANCA-associated vasculitis. The strong 
association between increasing age and increased incidence of ANCA-
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associated vasculitis found in this study suggests that the number of cases 
requiring treatment is likely to increase as the population ages, and we predict 
a 34% increase in the number incident cases annually in the UK over the next 
20 years if our study area is representative of the UK. It is important to note 
that this projection is based solely on anticipated changes to the age 
demographic and will not account for changes in environmental influences 
which may be important (e.g. dust exposure) and which may also change 
throughout this time period. Increasing numbers of patients from BME 
communities may be seen if the BME age structure becomes more similar to 
the White population. 
 
To conclude, the overall incidence of ANCA-associated vasculitis in 
Nottingham/Derby UK was similar to other epidemiological studies in the UK 
and worldwide. Further work to confirm these findings and explore the 
relationship with ethnicity further should be conducted in larger datasets, for 
example using the UK databases of routinely collected healthcare data, which 
have routinely collected ethnicity data since 1991(22,23). 
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Legends for illustrations: 
Figure 1  
Study area: The contiguous Nottingham and Derby urban areas. The area 
enclosed by the red line is the study population. 
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Key messages: 
1. The incidence of ANCA-associated vasculitis in the Midlands of the UK 
was estimated at 23.1/million person-years. 
2. The age-and-sex-adjusted incidence in the BME and White populations 
was similar. 
3. The annual number of new cases of ANCA-associated vasculitis in the UK 
is estimated to increase by 34% over the next 20 years due to the aging 
population. 
